Search

Your search keyword '"Anguela, Xavier M"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Anguela, Xavier M" Remove constraint Author: "Anguela, Xavier M"
40 results on '"Anguela, Xavier M"'

Search Results

1. ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma

6. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies

7. Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates

9. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant

11. Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

12. In vivo genome editing restores haemostasis in a mouse model of haemophilia

16. Preclinical development of , an investigational liver-directed AAV gene therapy for the treatment of Pompe disease

17. Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year

19. A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

20. Preclinical development of SPK-3006, an investigational liver-directed AAV gene therapy for the treatment of Pompe disease

22. Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Mean Factor IX Activity Levels of >30% without Immunosuppression

29. Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B - 1 Year Follow up and Impact of Baseline Characteristics on Transgene-Derived Factor IX Activity and Persistence

31. ZFN Mediated Targeting Of Albumin “Safe Harbor” Results In Therapeutic Levels Of Human Factor VIII In a Mouse Model Of Hemophilia A

32. Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys

34. In Vivo Genome Editing of Liver Albumin for Therapeutic Gene Expression: Rescue of Hemophilic Mice Via Integration of Factor 9

35. A Novel Strategy to Circumvent Pre-Existing Humoral Immunity to AAV

37. In vivo genome editing restores haemostasis in a mouse model of haemophilia.

38. In VivoGenome Editing in Neonatal Mouse Liver Preferentially Utilizes Homology Directed Repair

Catalog

Books, media, physical & digital resources